Share This Page
Drug Price Trends for SM ANTACID
✉ Email this page to a colleague
Average Pharmacy Cost for SM ANTACID
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| SM ANTACID 750 MG CHEW TABLET | 70677-0065-01 | 0.03230 | EACH | 2024-12-18 |
| SM ANTACID-ANTIGAS LIQUID | 70677-0115-01 | 0.01068 | ML | 2024-12-18 |
| SM ANTACID 500 MG CHEW TABLET | 70677-0067-01 | 0.01673 | EACH | 2024-12-18 |
| SM ANTACID MAX STRENGTH SUSP | 49348-0303-39 | 0.01160 | ML | 2024-12-18 |
| SM ANTACID 500 MG CHEW TABLET | 70677-0137-01 | 0.01673 | EACH | 2024-12-18 |
| SM ANTACID 500 MG CHEW TABLET | 70677-0137-01 | 0.01692 | EACH | 2024-11-20 |
| SM ANTACID MAX STRENGTH SUSP | 49348-0303-39 | 0.01124 | ML | 2024-11-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Global Antacids Market Analysis and Price Projections
The global antacids market is poised for significant growth, driven by increasing prevalence of gastrointestinal disorders, lifestyle changes, and the rising demand for over-the-counter (OTC) medications. Here’s a comprehensive analysis of the market trends, key players, and price projections.
Market Size and Growth Rate
The global antacids market is expected to expand substantially over the next few years. As of 2023, the market size was valued at approximately USD 6.8 billion and is projected to reach USD 8.2 billion by 2028, growing at a Compound Annual Growth Rate (CAGR) of 3.7% during the forecast period[1].
Another report indicates that the market size was USD 7.2 billion in 2022 and is estimated to grow to USD 10.9 billion by 2032, with a CAGR of 4.8% from 2024 to 2032[2].
Regional Market Analysis
North America
North America holds the largest share of the global antacids market, primarily due to the increasing prevalence of gastroesophageal reflux disease (GERD) and lifestyle changes leading to gastrointestinal problems among the population. The trend towards self-medication in North American countries, such as the United States, further boosts the demand for OTC digestive products, including antacids[1].
Asia Pacific
The Asia Pacific region is expected to be the fastest-growing market for antacids. Factors such as a high number of unmet clinical needs, efficient treatment options, rising disposable income, and increasing consumer awareness of available products contribute to this growth. Countries in this region are experiencing a surge in heartburn and GERD cases, which is propelling the market forward[4].
Key Players
The global antacids market is dominated by several key players, including:
- Sun Pharmaceuticals Ltd
- Sanofi S.A
- Bayer AG
- Johnson & Johnson
- Haleon
- Reckitt Benckiser Group plc
- GlaxoSmithKline plc
- Pfizer Inc.
- Boehringer Ingelheim International GmbH
- Dr. Reddy’s Laboratories Ltd.
- Procter & Gamble
- Takeda Pharmaceutical Company Limited[1][2].
Market Segmentation
The antacids market is segmented based on several criteria:
By Drug Class
- Proton Pump Inhibitors (PPIs)
- H2-Receptor Antagonists
- Acid Neutralizers
PPIs hold the maximum share of the antacids market due to their effectiveness in reducing stomach acid production[2].
By Formulation Type
- Tablets
- Liquid
- Powder
- Others
Tablets are the most common formulation type, but liquid and powder forms are also gaining popularity[2][3].
By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
The ease of access to antacids through various distribution channels, especially online pharmacies, is driving market growth[2][3].
Impact of COVID-19
The COVID-19 pandemic had a dual impact on the antacids market. Initially, it led to declining production and higher prices due to labor shortages. However, the pandemic also highlighted the importance of antacids in managing acidosis in COVID-19 patients, which increased demand and revenue for the market. For instance, research suggested that antacid therapy was necessary for COVID-19 patients with acidosis, indicating a positive feedback loop where SARS-CoV-2 infection-induced acidosis enhanced the infection[1].
Price Projections
Given the growth projections, the prices of antacids are expected to remain competitive but may see a slight increase due to rising demand and production costs.
-
Market Size Projections:
- By 2028, the market is expected to reach USD 8.2 billion[1].
- By 2032, the market is projected to reach USD 10.9 billion[2].
- By 2030, the market is anticipated to be worth USD 9.756 billion[3].
-
Price Trends:
- The increasing demand and the need for innovative formulations may lead to a slight increase in prices, but competition among key players will keep prices relatively stable.
- Regulatory approvals, such as the FDA approval for Famotidine tablets, will also influence pricing strategies[1].
Consumer Trends and Preferences
The market is driven by several consumer trends:
- Rising Prevalence of Gastrointestinal Disorders: The increasing cases of GERD, heartburn, and indigestion are driving the demand for antacids.
- Lifestyle Changes: The consumption of processed and fast foods is contributing to gastrointestinal problems, thereby increasing the demand for antacids[4].
- Self-Medication: The trend towards self-medication, especially in North America, is boosting the sales of OTC antacids[1].
Key Takeaways
- The global antacids market is expected to grow significantly, driven by increasing gastrointestinal disorders and lifestyle changes.
- North America holds the largest market share, while the Asia Pacific region is the fastest-growing market.
- Key players such as Sun Pharmaceuticals Ltd, Sanofi S.A, and Bayer AG dominate the market.
- The market is segmented by drug class, formulation type, and distribution channel.
- The COVID-19 pandemic highlighted the importance of antacids in managing acidosis in patients.
FAQs
What is the current global antacids market size?
The global antacids market size was approximately USD 6.8 billion in 2023 and is projected to reach USD 8.2 billion by 2028[1].
Who are the key players in the global antacids market?
Key players include Sun Pharmaceuticals Ltd, Sanofi S.A, Bayer AG, Johnson & Johnson, and Haleon among others[1][2].
Which region is the fastest-growing market for antacids?
The Asia Pacific region is expected to be the fastest-growing market due to several factors including high unmet clinical needs and rising consumer awareness[4].
What are the main factors driving the growth of the antacids market?
The main factors include the rising prevalence of gastrointestinal disorders, lifestyle changes, and the increasing trend towards self-medication[1][4].
How did the COVID-19 pandemic impact the antacids market?
The pandemic initially led to declining production and higher prices but later increased demand due to the need for antacid therapy in managing acidosis in COVID-19 patients[1].
Sources
- Mordor Intelligence: Antacids Market Report | Industry Analysis, Size & Forecast Overview
- Acumen Research and Consulting: Antacids Market Size, Share, Trends | Forecast 2032
- Data Bridge Market Research: Global Antacids Market – Industry Trends and Forecast to 2030
- Towards Healthcare: Antacids Market Size, Trends & 3.30% CAGR Growth by 2034
- OpenPR: Antacid Market to Reach USD 9.95 Bn by 2029: Competitive landscape, trends, statistics, and segmentation.
More… ↓
